The store will not work correctly when cookies are disabled.
N,N-Dimethyl-N'-(10-nitropyrido[3,4-g]quinazolin-2-yl)formimidamide
ID: ALA4533476
PubChem CID: 155547424
Max Phase: Preclinical
Molecular Formula: C14H12N6O2
Molecular Weight: 296.29
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)/C=N/c1ncc2cc3cnccc3c([N+](=O)[O-])c2n1
Standard InChI: InChI=1S/C14H12N6O2/c1-19(2)8-17-14-16-7-10-5-9-6-15-4-3-11(9)13(20(21)22)12(10)18-14/h3-8H,1-2H3/b17-8+
Standard InChI Key: HVOYIQYPVREKPR-CAOOACKPSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
9.3137 -6.2073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3126 -7.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0206 -7.4358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7303 -7.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0188 -5.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7238 -6.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4267 -5.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0162 -4.9889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3067 -4.5834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3031 -3.7662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6008 -4.9951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7162 -4.5796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4250 -4.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1279 -4.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1231 -3.7569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4096 -3.3541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7096 -3.7678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4015 -2.5369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1051 -2.1213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0970 -1.3042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8006 -0.8886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3852 -0.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 1 1 0
5 6 1 0
6 7 2 0
7 13 1 0
12 8 1 0
8 5 2 0
8 9 1 0
9 10 1 0
9 11 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
20 22 1 0
M CHG 2 9 1 10 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.29 | Molecular Weight (Monoisotopic): 296.1022 | AlogP: 2.31 | #Rotatable Bonds: 3 |
Polar Surface Area: 97.41 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.12 | CX LogP: 1.42 | CX LogD: 1.42 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.24 | Np Likeness Score: -0.76 |
References
1. Zeinyeh W, Esvan YJ, Josselin B, Baratte B, Bach S, Nauton L, Théry V, Ruchaud S, Anizon F, Giraud F, Moreau P.. (2019) Kinase inhibitions in pyrido[4,3-h] and [3,4-g]quinazolines: Synthesis, SAR and molecular modeling studies., 27 (10): [PMID:30967303] [10.1016/j.bmc.2019.04.005] |